biospecimen__admin__batch_number	287.61.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	099A3A8B-4765-4E14-905B-087F0C4C8753
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-A5SI-01A-31R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-A5SI-01A-31
biospecimen__bio__bcr_sample_barcode	TCGA-G3-A5SI-01A
biospecimen__bio__biospecimen_barcode_bottom	0145632901
biospecimen__bio__day_of_creation	26
biospecimen__bio__day_of_shipment	25
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-G3-A5SI.C3CB3D42-9123-4D51-9FA8-D272D5F62F7B.pdf
biospecimen__bio__plate_column	2
biospecimen__bio__plate_id	A27V
biospecimen__bio__plate_row	C
biospecimen__bio__portion_sequence	3
biospecimen__bio__quantity	2.21
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-G3-A5SI
biospecimen__shared__patient_id	A5SI
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-G3-A5SI-A42749
clinical__ablation__bcr_ablation_uuid	79DD2140-0ABD-4E38-86EB-5D34A1015117
clinical__ablation__days_to_embolization_performed	370
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Doxorubicin
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Plastic Beads
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	1F154FC1-8456-49F3-ADD7-5117821325C5
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.3
clinical__chol_lihc_shared__albumin_result_specified_value	2.8
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.7
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.4
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	9
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis C
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.4
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	44
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-A5SI-F59276
clinical__clin_shared__bcr_followup_uuid	E0D448CC-F26E-4F31-AA6A-A4D1573B06A9
clinical__clin_shared__day_of_form_completion	30
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	5
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	145
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	348
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__rx__bcr_drug_barcode	TCGA-G3-A5SI-D59275
clinical__rx__bcr_drug_uuid	EF0713F1-6FF0-47EA-92BC-BE9682F0B8A6
clinical__rx__days_to_drug_therapy_end	733
clinical__rx__days_to_drug_therapy_start	599
clinical__rx__drug_name	Sorafenib
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	ddb29159-cbe9-4b6d-a86f-8115b859b2bb
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-A5SI-01A-31R-A27V-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	d849a4a2-a420-4809-a067-3990a84b7270,9548646e-84e1-4951-9f50-1e2da1cc9f4e,e0f9b312-6e29-48c9-b1d3-1c27f98cf10f
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM,HTSeq - Counts,HTSeq - FPKM-UQ
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.83
gdc__analytes__analyte_id	0a23a58d-f9ec-48e6-8c70-d30d5003fb49
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	14201da5-4446-47be-af72-120b7780c6bf
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-26T21:15:07.636830-05:00,2016-05-26T21:15:07.181775-05:00,2016-05-26T21:15:07.457548-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	91f46c41-312f-5c8b-b45b-de7c588078cd
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1967
gdc__diagnoses__age_at_diagnosis	16126
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-16126.0
gdc__diagnoses__days_to_death	768.0
gdc__diagnoses__days_to_last_follow_up	447.0
gdc__diagnoses__diagnosis_id	9929bde9-ac3a-53dd-ac6f-5a2668667141
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	23.620287912158062
gdc__exposures__exposure_id	eb668c7c-d5ea-5b76-8e8c-a7fd2e36799b
gdc__exposures__height	177.0
gdc__exposures__weight	74.0
gdc__file_id	ee8860c7-1276-47ab-8025-0fc70e29b3c1,b3347c4b-6a21-449c-b8d4-202c0a745582,58043bb0-57c9-49ec-b1c1-bd7f5a09cfa9
gdc__file_name	f3b485c8-7f7b-4827-8d79-e3a070d52222.FPKM.txt.gz,f3b485c8-7f7b-4827-8d79-e3a070d52222.htseq.counts.gz,f3b485c8-7f7b-4827-8d79-e3a070d52222.FPKM-UQ.txt.gz
gdc__file_size	467829,241052,469168
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	6d5faa079f55c4e54c93933e1519f9c7,41645649cadbc10a0af7f4855cb94cde,2afb343991f4ccf6535cd6fa9d8a3e80
gdc__portions__is_ffpe	false
gdc__portions__portion_id	608a03fe-1cd9-4cf1-a067-8cb9c038ea6d
gdc__portions__portion_number	31
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	418
gdc__samples__initial_weight	660.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	C3CB3D42-9123-4D51-9FA8-D272D5F62F7B
gdc__samples__sample_id	81ade549-b8a5-4cbe-9970-1be85c005002
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	5.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	10.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	94.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	b40b50b8-a2f1-4bb0-82e9-38892432514e
gdc__submitter_id	f3b485c8-7f7b-4827-8d79-e3a070d52222_fpkm,f3b485c8-7f7b-4827-8d79-e3a070d52222_count,f3b485c8-7f7b-4827-8d79-e3a070d52222_uqfpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	dd3f4e6b-8725-5fde-875b-2f943742d78b
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:11:17.168+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/ddb29159-cbe9-4b6d-a86f-8115b859b2bb-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/ddb29159-cbe9-4b6d-a86f-8115b859b2bb-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	4981593
manually_curated__local_md5	51cdc544de22f8e97a21578b8b11688f
manually_curated__opengdc_download_date	2018-10-15T16:20:17.000511+02:00
manually_curated__opengdc_file_md5	ab386d2397d1f2b1f75e73c3021b1464
manually_curated__opengdc_file_size	1253510
manually_curated__opengdc_id	ddb29159-cbe9-4b6d-a86f-8115b859b2bb-geq
manually_curated__origin_file_size	4981593
manually_curated__origin_last_modified_date	Mon Oct 15 16:35:00 CEST 2018
manually_curated__origin_md5	51cdc544de22f8e97a21578b8b11688f
manually_curated__tissue_status	tumoral
num	60483
